galantamine and Smoking Cessation

galantamine has been researched along with Smoking Cessation in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brede, E; MacLean, RR; Sofuoglu, M; Waters, AJ	1
Liu, X	1
Boggs, DL; Buchanan, RW; Conley, RR; Dickinson, D; Kelly, DL; McMahon, RP; Weiner, E	1
Creeden, C; George, TP; Reutenauer, EL; Sacco, KA	1
Blendy, JA; Hayes, MR; Hopkins, TJ; Rupprecht, LE; Schmidt, HD	1
Herman, AI; Li, Y; Sofuoglu, M; Waters, AJ	1
Batra, A; Croissant, B; Diehl, A; Mann, K; Nakovics, H; Smolka, MN	1

Trials

5 trial(s) available for galantamine and Smoking Cessation

Article	Year
Effects of galantamine on smoking behavior and cognitive performance in treatment-seeking smokers prior to a quit attempt. Human psychopharmacology, 2018, Volume: 33, Issue:4 Topics: Adult; Cholinesterase Inhibitors; Cognition; Cotinine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Nootropic Agents; Patient Acceptance of Health Care; Patient Satisfaction; Smokers; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome	2018
Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia. Schizophrenia research, 2008, Volume: 103, Issue:1-3 Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Antipsychotic Agents; Breath Tests; Carbon Monoxide; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Male; Middle Aged; Nootropic Agents; Psychiatric Status Rating Scales; Psychotic Disorders; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking Cessation	2008
Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia. Schizophrenia research, 2008, Volume: 103, Issue:1-3 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Attention; Cognition Disorders; Double-Blind Method; Female; Galantamine; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation	2008
Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report. Psychopharmacology, 2012, Volume: 224, Issue:3 Topics: Behavior, Addictive; Blood Pressure; Cholinesterase Inhibitors; Cognition; Connecticut; Cross-Over Studies; Double-Blind Method; Female; Galantamine; Heart Rate; Humans; Infusions, Intravenous; Logistic Models; Male; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pilot Projects; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Task Performance and Analysis; Time Factors; Tobacco Use Disorder	2012
Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial. International journal of clinical pharmacology and therapeutics, 2006, Volume: 44, Issue:12 Topics: Administration, Cutaneous; Adult; Alcoholism; Cholinesterase Inhibitors; Cotinine; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Sex Factors; Skin Diseases; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome	2006

Other Studies

2 other study(ies) available for galantamine and Smoking Cessation

Article	Year
Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration. Psychopharmacology, 2013, Volume: 230, Issue:2 Topics: Allosteric Regulation; Animals; Azetidines; Dose-Response Relationship, Drug; Galantamine; Hydrocarbons, Brominated; Indole Alkaloids; Male; Nicotine; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement Schedule; Self Administration; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder	2013
Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:10 Topics: Allosteric Regulation; Animals; Cholinesterase Inhibitors; Drug-Seeking Behavior; Extinction, Psychological; Galantamine; Male; Nicotine; Rats; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder	2012

Article

Year

Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.

Psychopharmacology, 2013, Volume: 230, Issue:2

Topics: Allosteric Regulation; Animals; Azetidines; Dose-Response Relationship, Drug; Galantamine; Hydrocarbons, Brominated; Indole Alkaloids; Male; Nicotine; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement Schedule; Self Administration; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder

2013

Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:10

Topics: Allosteric Regulation; Animals; Cholinesterase Inhibitors; Drug-Seeking Behavior; Extinction, Psychological; Galantamine; Male; Nicotine; Rats; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder

2012